Categories: Latest

Dr Datsons Labs to make nutraceuticals for Belgium firm

To receive $17 m from Belgium’s Eubage over 18 months

Kolkata, February 2015

Mumbai-based contract drug-maker Dr Datsons Labs Ltd will manufacture nutraceuticals for Belgium company Eubage.

Kannan Viswanth, Vice-Chairman and MD of Dr Datsons Labs, told BusinessLine that the company would sign a definitive agreement with Eubage in March for manufacturing 20 nutraceuticals at its Pune formulations plant.

“The renewable contract ensures revenue flow of $17 million (Rs.105 crore now) for 18 months. This contract would also lend visibility for the company in Europe and the US. According to the arrangement, Dr Datsons would be recognised as the manufacturer of the products under licence from Eubage,” Viswanth added. Dr Datsons has two generics manufacturing and research establishments – one in Pune and the other at Mahad in Raigad district, Maharashtra. The Pune unit manufactures pain relief pharmaceuticals (syrups and lozenges) for Glenmark and Cipla. Its excess capacity would be utilised for making nutraceuticals. The Mahad plant is engaged in developing 15 active pharmaceutical ingredients.

FCCB conversion

The company, which had raised funds through foreign currency convertible bonds, has converted bonds worth around $10 million into equity this financial year. “According to indications, the bondholders of the remaining $10 million FCCBs are likely to convert the instruments into equity in the next fiscal. This would bring up the paid-up capital of the company to around Rs.11.5 crore,” Viswanath said. This would also reduce the finance cost of bonds servicing by around 10 per cent. “These conversions have brought down promoter holding from over 10 per cent in March 2014 to just about 1 per cent in January this year. Next fiscal, if further conversion takes place, there would be no promoter of the company, which would be run by professionals aided by a board comprising investment funds,” he said.

With the new revenue stream in nutraceuticals and lower finance cost, Dr Datson Labs could look forward to improvement in profit in 2015-16, he added. Business Line

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

2 days ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

2 days ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

3 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

3 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

4 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

4 days ago